Phillip Broadwith
As Business editor, my aim is to highlight to readers the exciting and innovative chemistry going on in the commercial sector, as well as keeping you abreast of trends and developments in the world of chemistry businesses.
From the point I left school, my aim was to join the pharmaceutical industry. A gap year and summer placements in company labs, and a PhD in organic synthesis followed.
But halfway through my PhD I entered a writing competition run by the Daily Telegraph. I managed to win – somewhat to my own surprise. That changed my perspective and made me think that I should consider writing more seriously as a career. I joined the Royal Society of Chemistry just before submitting my thesis, and luckily a position with Chemistry World came up a few months later. I sometimes miss the thrills (less so the spills) of lab work, but interacting with world-leading scientists and industrialists, as well as learning new things on a daily basis more than makes up for it.
BusinessFour dead in boiler explosion at Indian chemical plant
11 others injured as blast destroys adjacent temporary worker accommodation
- Business
US judge overturns Purdue’s opioid bankruptcy settlement
Ruling says bankruptcy court did not have authority to grant Sackler family protection from future litigation
- Opinion
When regulatory cooperation goes too far, we all lose
Were FDA staff unduly influenced by Biogen in approving Alzheimer’s antibody?
- Business
Fatal incident in German chemicals park
One dead and five injured by caustic soda being used for cleaning work
- Business
Diversity is at the heart of innovation
To challenge conventions we need to include people who think differently
- Opinion
A clouded view of industry emissions
Standards and auditing are sorely needed if emissions targets are to be upheld
- Business
Pfizer sues former employee for alleged trade secret theft
Chun Xiao Li downloaded thousands of confidential documents before resigning
- Business
Chemical plant fire in Pakistan kills at least 17 workers
Blocked windows and exits hampered rescue efforts
- Business
Massive fire at UK polyurethanes plant
One worker remains missing a week after Leamington Spa incident
- Business
Deadly explosion and fire at chemicals park in Germany
At least 2 dead and 31 injured when an explosion led to a solvent tank fire in Leverkusen
- Business
BMS and Eisai agree antibody-drug conjugate commercialisation deal
Companies will jointly develop cancer treatment, with BMS paying up to $3 billion for shared rights
- Business
Morphosys agrees to buy cancer epigenetics specialist Constellation
$1.7bn deal will be funded by selling rights to royalties on existing drugs
- Business
Fatal explosion at US paint and polymers plant
One dead and nine others injured as building partially collapsed after explosion and fire
- Business
4 dead in UK sewage treatment works explosion
One person injured as biosolids silo explodes at Avonmouth
- Opinion
A promising peep at Covid-19 vaccine efficacy
Pfizer–BioNTech’s will need to be one of many if we are to overcome the pandemic
- Business
Innovation is a fragile transition state
Brexit and Covid-19 will likely stifle interactions, but could also stimulate new ones
- Opinion
Improving executive diversity is a priority
A few hiring decisions could make a big difference at leadership level
- Podcast
Sofosbuvir
The hepatitis C drug that made waves when first launched – quicker to work and with fewer side effects than existing drugs, but it came with a hefty price tag
